Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0443 | 1 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0443 | 1 | 0.5 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0273 | 0.2407 | 0.2407 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0443 | 1 | 1 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0443 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0443 | 1 | 0.5 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0223 | 0.0151 | 0.0151 |
Brugia malayi | FAD binding domain containing protein | 0.0443 | 1 | 1 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0443 | 1 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0443 | 1 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0443 | 1 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0443 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0443 | 1 | 0.5 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0443 | 1 | 0.5 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0392 | 0.7743 | 0.5 |
Trypanosoma cruzi | p450 reductase, putative | 0.0443 | 1 | 0.5 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.022 | 0 | 0.5 |
Chlamydia trachomatis | sulfite reductase | 0.0273 | 0.2407 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0392 | 0.7743 | 0.5 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0443 | 1 | 1 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0443 | 1 | 0.5 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0443 | 1 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0443 | 1 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0443 | 1 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0443 | 1 | 1 |
Leishmania major | p450 reductase, putative | 0.0443 | 1 | 1 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0443 | 1 | 0.5 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.022 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0443 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 778 nM | Cytotoxicity measured using the H69 parental (H69/P) human small cell lung carcinoma cell line | ChEMBL. | 11806724 |
IC50 (functional) | = 778 nM | Cytotoxicity measured using the H69 parental (H69/P) human small cell lung carcinoma cell line | ChEMBL. | 11806724 |
IC50 (functional) | = 925 nM | Cytotoxicity measured using the drug resistant, P-glycoprotein (Pgp) expressing human small cell lung carcinoma cell line H69/LX4 | ChEMBL. | 11806724 |
IC50 (functional) | = 925 nM | Cytotoxicity measured using the drug resistant, P-glycoprotein (Pgp) expressing human small cell lung carcinoma cell line H69/LX4 | ChEMBL. | 11806724 |
Rf (functional) | = 1.2 | Rf is the resistance factor and is the ratio of the IC50 on the resistant cell line over the IC50 on the parental H69/P cell line | ChEMBL. | 11806724 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 11806724 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.